The proportion of CD64+CD14+ and CD32+ CD14+ cells in PBMCs was about 3%, which accounts for almost all monocytes, but the proportion of CD16+ CD14+ cells was only about 1% in healthy controls and SLE patients (Figure 1A). The gene discussed is FCGR2A; the disease is systemic lupus erythematosus.